Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
8,300
Price
$26.83
Total Value
$222.65K
Shares Held After
395,775
% of Holdings
2.1%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
136,193
Price
$13.59
Total Value
$1.85M
Shares Held After
3,378,621
% of Holdings
3.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
136,193
Price
$13.58
Total Value
$1.85M
Shares Held After
3,378,546
% of Holdings
3.9%
Harmony Biosciences Holdings, Inc. (HRMY)
Kapadia Sandip — CHIEF FINANCIAL OFFICER
Shares
20,961
Price
$35.92
Total Value
$752.83K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
6,303
Price
$19.89
Total Value
$125.36K
Shares Held After
1,005,732
% of Holdings
0.6%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
5,590
Price
$19.89
Total Value
$111.18K
Shares Held After
890,604
% of Holdings
0.6%
Nkarta, Inc. (NKTX)
HASTINGS PAUL J — Director
Shares
26,046
Price
$2.07
Total Value
$53.92K
Shares Held After
390,023
% of Holdings
6.3%
Nkarta, Inc. (NKTX)
Mahmood Nadir — President
Shares
5,649
Price
$2.07
Total Value
$11.69K
Shares Held After
167,727
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
149
Price
$18.02
Total Value
$2.68K
Shares Held After
213,992
% of Holdings
0.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
559
Price
$35.40
Total Value
$19.79K
Shares Held After
97,038
% of Holdings
0.6%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
15,959
Price
$34.72
Total Value
$554.07K
Shares Held After
97,597
% of Holdings
14.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
2,111
Price
$33.62
Total Value
$70.98K
Shares Held After
113,556
% of Holdings
1.8%
Immuneering Corp (IMRX)
Schall Thomas J. — Director
Shares
21,645
Price
$4.67
Total Value
$101.04K
Shares Held After
74,530
% of Holdings
29.0%
AnaptysBio, Inc. (ANAB)
Marquet Magda — Director
Shares
1,710
Price
$48.85
Total Value
$83.53K
Shares Held After
9,930
% of Holdings
14.7%
AnaptysBio, Inc. (ANAB)
Marquet Magda — Director
Shares
9,290
Price
$48.12
Total Value
$447.00K
Shares Held After
11,640
% of Holdings
44.4%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,563
Price
$5.10
Total Value
$64.07K
Shares Held After
650,298
% of Holdings
1.9%
Olema Pharmaceuticals, Inc. (OLMA)
Kovacs Shane William Charles — CH. OPERATING & FINANCIAL OFF.
Shares
100,000
Price
$28.73
Total Value
$2.87M
Shares Held After
139,727
% of Holdings
41.7%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
37,413
Price
$0.55
Total Value
$20.58K
Shares Held After
2,198,642
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
40
Price
$474.74
Total Value
$18.99K
Shares Held After
36,781
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,576
Price
$471.44
Total Value
$742.99K
Shares Held After
36,821
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
3,531
Price
$469.34
Total Value
$1.66M
Shares Held After
38,397
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
407
Price
$472.28
Total Value
$192.22K
Shares Held After
41,928
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,307
Price
$470.37
Total Value
$614.77K
Shares Held After
42,335
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,439
Price
$468.32
Total Value
$673.92K
Shares Held After
43,642
% of Holdings
3.2%
Olema Pharmaceuticals, Inc. (OLMA)
Harmon Cyrus — Director
Shares
3,489
Price
$29.12
Total Value
$101.60K
Shares Held After
737,770
% of Holdings
0.5%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
13,112
Price
$45.20
Total Value
$592.61K
Shares Held After
108,964
% of Holdings
10.7%
Acrivon Therapeutics, Inc. (ACRV)
Blume-Jensen Peter — Director
Shares
49,000
Price
$1.68
Total Value
$82.12K
Shares Held After
2,095,771
% of Holdings
2.3%
Acrivon Therapeutics, Inc. (ACRV)
Levy Adam D. — Chief Financial Officer
Shares
8,832
Price
$1.70
Total Value
$15.00K
Shares Held After
20,983
% of Holdings
42.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
470
Price
$83.79
Total Value
$39.38K
Shares Held After
1,192,987
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
5,386
Price
$83.16
Total Value
$447.90K
Shares Held After
1,193,457
% of Holdings
0.4%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,854
Price
$82.41
Total Value
$152.79K
Shares Held After
1,198,843
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,374
Price
$81.00
Total Value
$192.29K
Shares Held After
1,200,697
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,476
Price
$79.82
Total Value
$676.55K
Shares Held After
1,203,071
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
1,440
Price
$78.64
Total Value
$113.24K
Shares Held After
1,211,547
% of Holdings
0.1%
ZIVO Bioscience, Inc. (ZIVO)
Maggiore Christopher D. — Director
Shares
1,766
Price
$8.49
Total Value
$14.99K
Shares Held After
519,292
% of Holdings
0.3%
ZIVO Bioscience, Inc. (ZIVO)
YALDOO LAITH L — Director
Shares
1,766
Price
$8.49
Total Value
$14.99K
Shares Held After
579,638
% of Holdings
0.3%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
19,621
Price
$5.12
Total Value
$100.46K
Shares Held After
662,861
% of Holdings
2.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
11,367
Price
$32.61
Total Value
$370.64K
Shares Held After
50,437
% of Holdings
18.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
30,616
Price
$0.57
Total Value
$17.45K
Shares Held After
2,236,055
% of Holdings
1.4%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,927
Price
$19.99
Total Value
$58.51K
Shares Held After
999,429
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
2,596
Price
$19.99
Total Value
$51.89K
Shares Held After
885,014
% of Holdings
0.3%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
35,003
Price
$28.99
Total Value
$1.01M
Shares Held After
542,761
% of Holdings
6.1%
Olema Pharmaceuticals, Inc. (OLMA)
Myles David C. — CH. DISCOV. & NON-CLIN DEV OFF
Shares
14,997
Price
$28.60
Total Value
$428.91K
Shares Held After
577,764
% of Holdings
2.5%
Arcellx, Inc. (ACLX)
Heery Christopher — CHIEF MEDICAL OFFICER
Shares
5,882
Price
$68.51
Total Value
$403.00K
Shares Held After
23,749
% of Holdings
19.9%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
1,084
Price
$2.50
Total Value
$2.71K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
26,105
Price
$4.89
Total Value
$127.65K
Shares Held After
682,482
% of Holdings
3.7%
Showing 351–400 of 1179 transactions (page 8 of 24)